Boston Globe Ranks Momenta Pharmaceuticals Top Public Company Based
BOSTON--(BUSINESS WIRE)--May. 18, 2012--
The Boston Globe unveiled today its annual Globe 100 list ranking the
best-performing public companies in Massachusetts, and Momenta
Pharmaceuticals claims the number one spot. For the first time in three
years, the Globe 100 list features 100 companies. The recession took its
toll on Bay State firms in 2009 and 2010, making it difficult for many
of them to qualify for the Globe 100.
In this year’s 44-page Globe 100 Magazine, Momenta Pharmaceuticals Inc.
of Cambridge earned top honors, claiming the number one ranking. The
biotech company returns to the list after a two-year absence. It boosted
its revenues last year with its generic version of the
anti-blood-clotting drug Lovenox, which has already generated $1.5
billion in sales since its approval by the Food and Drug Adminstration
in the summer of 2010.
“The positive momentum we are seeing in the economic recovery is
illustrated by the Globe 100 returning to full strength,” said Shirley
Leung, business editor of The Boston Globe. “It’s a powerful testament
to the resiliency of Massachusetts’ businesses.”
Rounding out the top five companies are businesses in the
telecommunications, industrial, services and technology sectors. They
were IPG Photonics Corp. (#2); Altra Holdings (#3); Sapient Corp. (#4);
and Parametric Technology Corp. (#5).
The annual ranking of companies will be published on Sunday, May 20 in The
Boston Sunday Globe and at BostonGlobe.com/Globe100.
For the second year, the publication will also recognize the Most
Innovative in Massachusetts – men and women across a wide range of
industries who have contributed to our economy and community in
innovative ways over the past year, from the inventor of a bionic ankle
to the banker who mobilized the community to stop violence after a
The Globe assembled a panel of six esteemed judges to choose the state’s
12 best innovators from a pool of 186 qualified nominees in a variety of
key industries. Judges included Henri Termeer, former CEO of biotech
giant Genzyme Corp., Greg Selkoe, founder of online streetware retailer
Karmaloop, and well-known philanthropist Dan Pallotta, among others.
Innovators profiled include Mothers for Justice and Equality founder
Monalisa Smith, a banker who turned a family tragedy into a grassroots
peace movement to fight violence in the Dorchester neighborhood of
Boston; Matt Coates, innovation consultant at Invention Machine Corp. in
Boston, who has been working to create tools for eye surgery, new ways
to extract oil, and a product for fresher breath; and veteran healthcare
entrepreneur Donato Tramuto, who started the nonprofit Health eVillages
to introduce smartphone technology to caregivers in developing countries.
As part of the Globe 100, the Globe also convened an executive
roundtable to address the benefits and challenges of running post-IPO
companies, featuring Jeremy Allaire, chief executive of Boston-based
video services provider Brightcove Inc.; Robert Forrester, chief
operating officer at Verastem Inc. in Cambridge; and David Friend, chief
executive of Boston-based online computer back-up company Carbonite Inc.
Plus, the issue includes a feature on the unique job titles found in the
will feature all of the magazine’s coverage, along with video from
inside the best companies, videos of the innovators, photo galleries,
charts and more. Boston.com/Globe100
will also feature highlights of the magazine’s content. Readers can
follow updates on Twitter at @GlobeBiz and #globe100.
About the Globe 100 ranking methodology
The Globe 100 ranks Massachusetts-based public companies based on
financial data from the four quarters ending December 31, 2011. To be
eligible, the company must be traded publicly for the entire 2011
calendar year on the New York Stock Exchange, the Nasdaq or the American
Stock Exchange and report revenue and profit for both 2010 and 2011.
Companies are ranked on four criteria: return on average equity,
one-year percentage change in revenue, one-year percentage change in
profit margin and 2011 revenue.
About The Boston Globe:
The Boston Globe is wholly owned by the New York Times Company (NYSE:
NYT), a leading, global multimedia news and information company with
2011 revenues of $2.3 billion, that includes The New York Times, the
International Herald Tribune, The Boston Globe, NYTimes.com,
and related properties. The Company's core purpose is to enhance society
by creating, collecting and distributing high-quality news, information
Source: The Boston Globe
Jenny Long, 617-929-2645
Boston Globe Corporate Communications on Twitter @BGlobeComm